Estimate Recalculated Dec 3, 2025 08:07PM EST
Phillip Gross does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ORBCOMM Inc., HeartWare International, Inc., Royalty Pharma plc, Celanese Corp, SELECT COMFORT CORP, MULESOFT, INC, GCM Grosvenor Inc., Solaris Oilfield Infrastructure, Inc., HUBBELL INC, Protagonist Therapeutics, Inc, Mandalay Digital Group, Inc., PUMA BIOTECHNOLOGY, INC., Calithera Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., Advaxis, Inc., Nexvet Biopharma plc, AMCI Acquisition Corp., AMAG PHARMACEUTICALS INC., East Resources Acquisition Co, PACIFIC SUNWEAR OF CALIFORNIA INC, Vitae Pharmaceuticals, Inc, SMART BALANCE, INC., FIVE PRIME THERAPEUTICS INC, CARDIOME PHARMA CORP, Targanta Therapeutics Corp., GENEVA ACQUISITION CORP, ABEONA THERAPEUTICS INC., and EyePoint Pharmaceuticals, Inc..
Phillip Gross's CIK is 0001403413
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!